INCOR. Unique Periodic Flow Change Algorithm Promoting Native Aortic Valve Function During INCOR Therapy

Similar documents
Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Exchange solutes and water with cells of the body

Normal & Abnormal Intracardiac. Lancashire & South Cumbria Cardiac Network

Normal Intracardiac Pressures. Lancashire & South Cumbria Cardiac Network

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

Quiz 5 Heart Failure scores (n=163)

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Functional Improvement for Heart Failure Patients After Left Ventricular Assistive Device Placement in a Free Standing Rehabilitation Hospital

Berlin Heart EXCOR Ventricular Assist Device

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Riociguat Clinical Trial Program

Press conference: Rheumatic Heart Disease a forgotten but devastating disease

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment

SYNOPSIS. Risperidone: Clinical Study Report CR003274

Sponsor Novartis Pharmaceuticals

How should we treat atrial fibrillation in heart failure

1 Congestive Heart Failure & its Pharmacological Management

MEDICAL POLICY SUBJECT: VENTRICULAR ASSIST DEVICES. POLICY NUMBER: CATEGORY: Technology Assessment

Clinical Study Synopsis for Public Disclosure

INTRODUCTION TO EECP THERAPY

Chronic Vagus Nerve Stimulation: A New Treatment Modality for Congestive Heart Failure

Surgeons Role in Atrial Fibrillation

INHERIT. The Lancet Diabetes & Endocrinology In press

Advanced Heart Failure & Transplantation Fellowship Program

Educational Goals & Objectives

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Current status of pediatric cardiac surgery

Section Four: Pulmonary Artery Waveform Interpretation

Test Content Outline Effective Date: February 6, Cardiac-Vascular Nursing Board Certification Examination

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

1975 M.D. University of Maryland School of Medicine, Baltimore, Maryland Internship, University of Michigan Medical Center, Ann Arbor, MI

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Minimally Invasive Mitral Valve Surgery

Diagnostic and Therapeutic Procedures

Clinical Study Synopsis

Heart Report Cardiology and Cardiac Surgery - for Germany including a Europe-wide Comparison

5. Management of rheumatic heart disease

HYPERTROPHIC CARDIOMYOPATHY

Staphyloccus aureus sepsis: follow- up practice guidelines

Non-Invasive Positive Pressure Ventilation in Heart Failure Patients: For Who, Wy & When?

Section 8: Clinical Exercise Testing. a maximal GXT?

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Starling s Law Regulation of Myocardial Performance Intrinsic Regulation of Myocardial Performance

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

Treatment of Cardiac Device Infections

Vascular System The heart can be thought of 2 separate pumps from the right ventricle, blood is pumped at a low pressure to the lungs and then back

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, ESRD Registry Committee, Korean Society of Nephrology*

Potential Causes of Sudden Cardiac Arrest in Children

Echocardiography Guided Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure and Narrow QRS Complex

Guidance for Industry

Listen to your heart: Good Cardiovascular Health for Life

Anatomi & Fysiologi The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;

Practical class 3 THE HEART

Aortic Valve Stenosis and CAD

getemed Medizin- und Informationstechnik AG

Heart Sounds & Murmurs

HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

The heart then repolarises (or refills) in time for the next stimulus and contraction.

Heart Failure EXERCISES. Ⅰ. True or false questions (mark for true question, mark for false question. If it is false, correct it.

Cope Sample Small. Jeffrey T. Cope, M.D., Susan L. Sample, MSN, CRNP, and Roy S. Small, M.D.

Adult Cardiac Surgery ICD9 to ICD10 Crosswalks

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

Feeding in Infants with Complex Congenital Heart Disease. Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014

The P Wave: Indicator of Atrial Enlargement

Common types of congenital heart defects

Recurrent AF: Choosing the Right Medication.

EAE TEACHING COURSE Aorta and aortic valve 2012

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION

Case III. Disscussion. the UHP ultrasound protocol. Novel Ultrasound Approach to the Empiric Evaluation of the Undifferentiated Hypotensive Patient

Heart murmurs and heart disease

All Patient Refined DRGs (APR-DRGs) An Overview. Presented by Treo Solutions

EVALUATION OF MEDICAL RECORDS COMPLETENESS IN THE ADULT CARDIOLOGY CLINIC AT NORK MARASH MEDICAL CENTER

Electrocardiography Review and the Normal EKG Response to Exercise

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

From Lawrence Weed to Apex and ICD-10. Paul Brakeman MD PhD Physician Lead for Provider Practice Change and Education

Magnetic Resonance Quantitative Analysis. MRV MR Flow. Reliable analysis of heart and peripheral arteries in the clinical workflow

Isabella Sudano & Franco Muggli

Understanding your child s heart Atrial septal defect

Geriatric Cardiology: Challenges and Strategies

Transcatheter Mitral Valve-in-Valve and Valve-in-Ring Implantations. Danny Dvir, MD On behalf of VIVID registry investigators

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Auscultation of the Heart

on behalf of the AUGMENT-HF Investigators

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

MICROGRAVITY EFFECTS ON HUMAN PHYSIOLOGY: CIRCULATORY SYSTEM

May 1 6, 2016 Loews Atlanta Hotel Atlanta, GA PRELIMINARY PROGRAM AT A GLANCE

Transcription:

INCOR Unique Periodic Flow Change Algorithm Promoting Native Aortic Valve Function During INCOR Therapy Patrycja Ganslmeier MD (Universitätsklinikum Klinik für Herz- und Gefäßchirurgie Regensburg, Germany) Prof. Christof Schmid MD (Universitätsklinikum Klinik für Herz- und Gefäßchirurgie Regensburg, Germany) Attilio Iacovoni MD (Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy)

Aortic Valve Insufficiency in LVAD Therapy Continuous flow LVADs without Periodic Flow Change algorithm induce aortic valve insufficiency 1 π Development of aortic valve insufficiency (AI) 1 (mild to moderate) up to 52% during continuous flow (CF) LVAD support reported (no preoperative AI) 2 π Development of de novo AI during LVAD therapy is critical 4 and associated with: Exertion limitation Pulmonary congestion despite LVAD support Compromised net forward flow Possible surgical reintervention π Mortality doubled in patients with AI on continuous flow LVAD support (39% vs. 18%) 2 π Two potential mechanisms described that promote AI development: Aortic valve commissural fusion leads to valve fibrosis and degeneration² Aortic root dilatation with concomitant changes in wall elasticity and 3 chronically high diastolic aortic pressures π Independent risk factor for onset of AI: permanently closed aortic valve 2,3 2 1 Letsou et al., Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency?, J Heart Lung Transplant. 2006 Apr;25(4):395-9 2 Aggarwal et al., The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients, Ann Thorac Surg. 2013 Feb;95(2):493-8 3 Cowger et al., The development of aortic insufficiency in left ventricular assist devicesupported patients, Circ Heart Fail. 2010 Nov;3(6):668-74 4 Park, Aortic Insufficiency in LVAD Patients, oral communication ASAIO 59 th Annual Conference Chicago 2013 5 Iacovoni, Influence of Long Term INCOR therapy on aortic valve function, oral communication DGTHG 42 nd Annual Conference Freiburg 2013 6 Connelly et al., Acquired commissural fusion of aortic valves in patients with left ventricular assist devices, J Heart Lung Transplant. 2003 Dec;22(12):1291-5 7 John et al., Aortic valve pathophysiology during left ventricular assist device support, J Heart Lung Transplant. 2010 Dec;29(12):1321-9

Prevention of AI during LVAD therapy Acquired commissural fusion of aortic valves in patients on CF-LVAD support π Speed settings adjustment 4,5,7 π Blood pressure control 4,5 π Continuous echocardiography monitoring (M-mode interrogation of the aortic valve) FIGURE 1 Acquired commissural fusion of aortic valves in patients on CF-LVAD support (Adapted from Connelly, J Heart Lung Transplant. 2003 Dec;22(12):1291-5) Closed valves are prone to fusion and degeneration from lack of mobility in the setting of concomitant valve stress mediated by high pressure and velocity blood flow. 3 π Observing exercise tolerance and patients individual findings π INCOR Periodic Flow Change (PFC) algorithm 5 3 Freedom Aortic Valve from Insufficiency Primary Endpoint LVAD Therapy

INCOR Periodic Flow Change (PFC) Algorithm Operating principle of the INCOR PFC algorithm Speed Interval Set speed Duration of reduction Speed reduction Slew time Rise time Time FIGURE 2 Operating principle of the INCOR PFC algorithm The speed is reduced at fixed time intervals. After a defined period of speed reduction, the set speed is reinstated. Berlin Heart GmbH 4

Aortic valve function during LVAD support FIGURE 3A LVAD support without PFC during systole If the aortic valve is closed, the blood is ejected only through the LVAD. Berlin Heart GmbH FIGURE 3B LVAD support with PFC during systole The PFC algorithm induces the opening of the aortic valve. Berlin Heart GmbH 5 INCOR Periodic Flow Change (PFC) Algorithm

Influence of INCOR PFC Algorithm on Aortic Valve Function π Study type: Retrospective, multicenter* data analysis π Study objective: Influence of INCOR PFC algorithm on aortic valve function π Patient population: 16 patients (09/2008-01/2012) Follow-up at 6 month: 16 patients Follow-up at 12 month: 12 patients Pre-LVAD AI: 69% π *Trial sites: Universitätsklinikum Klinik für Herz- und Gefäßchirurgie Regensburg, Germany Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy 6

Pressure difference [mmhg] Speed [rpm] Detection of aortic valve opening by analyzing pressure difference characteristic Pressure difference Flow rate 120 6.0 100 5.0 80 4.0 60 3.0 40 1.0 20 0.0 0-1.0-2.0 0 2.79 5.58 Time [s] 0 2.79 5.58 10000 Speed 8000 6000 4000 2000 Flow rate (l/min) Aortic valve closed Aortic valve open FIGURE 4 Detection of aortic valve opening by analyzing pressure difference characteristic Data of an INCOR patient was analyzed who presented aortic valve opening only during PFC algorithm. The speed characteristic displays the PFC algorithm. Opening of the aortic valve can be monitored by analyzing the pressure difference curve. Aortic valve open: If the aortic valve opens during systole, an instant pressure drop in the left ventricle is seen. The pressure difference curve increased displaying the rapidly increasing pressure difference between the aorta and the left ventricle. After the aortic valve is closed, the pressure difference curve follows the primary characteristic. Aortic valve closed: If the aortic valve is closed, the pressure difference curve displays the pressure increase and decrease in the left ventricle. Blood is pumped only through the INCOR system. Berlin Heart GmbH 7 Influence of INCOR PFC Algorithm on Aortic Valve Function

Patient characteristics Demographic data Primary cardiac diagnosis INTERMACS level Characteristics Value Mean age [years] (range) 49.6 (19-68) Mean weight [kg] (range) 75.0 (60-103) Mean BMI [kg/m 2 ] (range) 24.3 (20.6-33.3) Mean BSA [m 2 ] (range) 1.9 (1.7-2.3) Gender All male Other 19% Ischemic cardiomyopathy 12% Dilative cardiomyopathy 69% INTERMACS level 3 25% INTERMACS level 1 6% INTERMACS level 2 69% FIGURE 5 Primary cardiac diagnosis FIGURE 6 INTERMACS level 75% of the patients presented with INTERMACS level 1 or 2. 8

Results Overall outcome Percentage of patients 100 80 60 40 20 94% 69% 25% 6% 0 0 6 12 Time on device [month] FIGURE 7 Overall outcome 1-year survival was 94%, thereof 25% of the patients have been transplanted and 69% are still on support. Survival on system Transplanted Deceased Aortic valve insufficiency (AI) AI [Percentage of patients] 100 80 60 40 20 0 31% 69% 19% 81% 31% 69% 67% 25% pre-op at discharge 6 month 12 month FIGURE 8 Aortic valve insufficiency (AI) At 6 months on LVAD support, no AI was detected in 31% of the patients compared to 19% during check-up at discharge. At 12 months, 8% of the patients developed a moderate AI. No severe AI developed in any patient. Reduction of early onset of AI during INCOR support with PFC 0 (none) 1 (mild) 8% 2 (moderate) 3 (severe) 9 Influence of INCOR PFC Algorithm on Aortic Valve Function

Opening of the aortic valve Aortic valve free of fusion after INCOR therapy Opening of aortic valve [% of patients] 100 80 60 40 20 0 56% 50% 50% 42% 31% 25% 25% 13% 8% Echo at discharge Follow-up 6 months Follow-up 12 months FIGURE 9 Opening of the aortic valve Full opening of the aortic valve increased during LVAD support to 31% of the patients within the first 6 months and decreased slightly during the next 6 months to 42% of the patients. Full opening Intermittent opening Full closure FIGURE 10 Aortic valve free of fusion after INCOR therapy (by courtesy of Dr. A. Iacovoni) No aortic valve fusion was detected in the heart of an INCOR patient after transplantation (time on device 13 months). 10

Conclusion INCOR Periodic Flow Change (PFC) algorithm π promotes the opening of the aortic valve by modulating the speed at fixed intervals π reduces the early onset of AI during INCOR support, despite permanently closed aortic valve in 50% of the patients Detection of aortic valve opening by pressure difference trend analysis facilitates speed adjustment to further induce aortic valve opening. 11 Influence of INCOR PFC Algorithm on Aortic Valve Function

INCOR Periodic Flow Change (PFC) algorithm π promotes the opening of the aortic valve by modulating the speed at fixed intervals π reduces the early onset of AI during INCOR support, despite permanently closed aortic valve in 50% of the patients Berlin Heart GmbH Wiesenweg 10 12247 Berlin Germany Phone +49 30 81 87-26 00 Fax +49 30 81 87-26 01 info@berlinheart.de www.berlinheart.de Berlin Heart Inc. 200 Valleywood Road Suite B100 The Woodlands TX 77380 USA Phone +1 281 863-97 00 Fax +1 281 863-97 01 info@berlinheart.com www.berlinheart.com Version MFI21.0 September 2013 Berlin Heart GmbH